iRhythm Technologies, Inc.

LSE:0A7L Stock Report

Market Cap: US$3.1b

iRhythm Technologies Past Earnings Performance

Past criteria checks 0/6

iRhythm Technologies's earnings have been declining at an average annual rate of -21.7%, while the Medical Equipment industry saw earnings declining at 5.9% annually. Revenues have been growing at an average rate of 21.2% per year.

Key information

-21.7%

Earnings growth rate

-17.5%

EPS growth rate

Medical Equipment Industry Growth-9.5%
Revenue growth rate21.2%
Return on equity-143.9%
Net Margin-25.3%
Last Earnings Update31 Mar 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How iRhythm Technologies makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

LSE:0A7L Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 24513-13037862
31 Dec 23493-12337060
30 Sep 23473-10535658
30 Jun 23452-9935453
31 Mar 23430-10534451
31 Dec 22411-11631747
30 Sep 22380-12830446
30 Jun 22362-13129743
31 Mar 22341-12427841
31 Dec 21323-10127539
30 Sep 21320-7926038
30 Jun 21306-5923838
31 Mar 21276-6321941
31 Dec 20265-4419741
30 Sep 20245-5119539
30 Jun 20228-6519144
31 Mar 20230-5519039
31 Dec 19215-5518037
30 Sep 19197-5416335
30 Jun 19181-4515027
31 Mar 19165-4814324
31 Dec 18147-5013321
30 Sep 18134-4512318
30 Jun 18120-4211117
31 Mar 18108-359615
31 Dec 1799-308513
30 Sep 1789-257311
30 Jun 1781-22659
31 Mar 1773-20578
31 Dec 1664-21527
30 Sep 1656-22487
30 Jun 1649-24457
31 Mar 1641-24406
31 Dec 1536-23376
30 Sep 1532-19316
31 Dec 1422-16206
31 Dec 1315-14144

Quality Earnings: 0A7L is currently unprofitable.

Growing Profit Margin: 0A7L is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 0A7L is unprofitable, and losses have increased over the past 5 years at a rate of 21.7% per year.

Accelerating Growth: Unable to compare 0A7L's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 0A7L is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (17.9%).


Return on Equity

High ROE: 0A7L has a negative Return on Equity (-143.94%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.